Genitrix, LLC
Genitrix, LLC is named on 0 US grants and 15 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 0
- Published applications
- 15
- Inventors
- 3
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 9 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
By publication year.
Technology areas
Share of 15 documents
Recent patents
No granted patents yet.
- CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen25 Nov 2010US 2010/0297154 A1
- Lectin compositions and methods for modulating an immune response to an antigen18 Nov 2010US 2010/0292453 A1
- Nucleic acid compositions and methods of introducing nucleic acids into cells30 Jul 2009US 2009/0191170 A1
- Cytokine-coated cells and methods of modulating an immune response to an antigen22 Nov 2007US 2007/0269455 A1
- Nucleic acid compositions and methods of introducing nucleic acids into cells14 Jul 2005US 2005/0153312 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.